rs1016792
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_005900.3(SMAD1):c.1255-164C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.813 in 152,088 control chromosomes in the GnomAD database, including 51,198 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.81 ( 51198 hom., cov: 30)
Consequence
SMAD1
NM_005900.3 intron
NM_005900.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.44
Publications
8 publications found
Genes affected
SMAD1 (HGNC:6767): (SMAD family member 1) The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signals of the bone morphogenetic proteins (BMPs), which are involved in a range of biological activities including cell growth, apoptosis, morphogenesis, development and immune responses. In response to BMP ligands, this protein can be phosphorylated and activated by the BMP receptor kinase. The phosphorylated form of this protein forms a complex with SMAD4, which is important for its function in the transcription regulation. This protein is a target for SMAD-specific E3 ubiquitin ligases, such as SMURF1 and SMURF2, and undergoes ubiquitination and proteasome-mediated degradation. Alternatively spliced transcript variants encoding the same protein have been observed. [provided by RefSeq, Jul 2008]
SMAD1 Gene-Disease associations (from GenCC):
- pulmonary arterial hypertensionInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 4-145557627-C-T is Benign according to our data. Variant chr4-145557627-C-T is described in ClinVar as Benign. ClinVar VariationId is 1227457.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.948 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMAD1 | ENST00000302085.9 | c.1255-164C>T | intron_variant | Intron 6 of 6 | 1 | NM_005900.3 | ENSP00000305769.4 | |||
| SMAD1 | ENST00000394092.6 | c.1255-164C>T | intron_variant | Intron 6 of 6 | 1 | ENSP00000377652.2 | ||||
| SMAD1 | ENST00000515385.1 | c.1255-164C>T | intron_variant | Intron 6 of 6 | 2 | ENSP00000426568.1 | ||||
| SMAD1 | ENST00000511125.1 | n.3005-164C>T | intron_variant | Intron 2 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.813 AC: 123586AN: 151970Hom.: 51147 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
123586
AN:
151970
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.813 AC: 123685AN: 152088Hom.: 51198 Cov.: 30 AF XY: 0.805 AC XY: 59804AN XY: 74300 show subpopulations
GnomAD4 genome
AF:
AC:
123685
AN:
152088
Hom.:
Cov.:
30
AF XY:
AC XY:
59804
AN XY:
74300
show subpopulations
African (AFR)
AF:
AC:
39682
AN:
41514
American (AMR)
AF:
AC:
9720
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
2636
AN:
3470
East Asian (EAS)
AF:
AC:
3166
AN:
5146
South Asian (SAS)
AF:
AC:
3674
AN:
4818
European-Finnish (FIN)
AF:
AC:
7923
AN:
10542
Middle Eastern (MID)
AF:
AC:
223
AN:
294
European-Non Finnish (NFE)
AF:
AC:
54395
AN:
68000
Other (OTH)
AF:
AC:
1653
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1088
2175
3263
4350
5438
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
876
1752
2628
3504
4380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2420
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Sep 04, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.